Published in J Mol Cell Cardiol on May 01, 1996
Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch Immunol Ther Exp (Warsz) (2009) 1.41
Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem J (2005) 1.20
Mechanisms and management of doxorubicin cardiotoxicity. Herz (2011) 1.05
Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure. Biochem Pharmacol (2005) 0.99
Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies. Biochem Res Int (2012) 0.86
Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications. Nitric Oxide (2012) 0.85
Mitochondrionopathy phenotype in doxorubicin-treated Wistar rats depends on treatment protocol and is cardiac-specific. PLoS One (2012) 0.77
Visnagin-a new protectant against doxorubicin cardiotoxicity? Inhibition of mitochondrial malate dehydrogenase 2 (MDH2) and beyond. Ann Transl Med (2016) 0.76
Binding of adriamycin to liposomes as a probe for membrane lateral organization. Biophys J (1999) 0.76
Common mechanism of toxicity: a case study of organophosphorus pesticides. Toxicol Sci (1998) 2.08
Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol (2006) 1.71
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res (2001) 1.25
Doxorubicin-induced persistent oxidative stress to cardiac myocytes. Toxicol Lett (2001) 1.10
Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol Sci (2002) 1.07
Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res B Dev Reprod Toxicol (2005) 0.98
Effect of aminophylline on adenosine and exercise dilation of rat cremaster arterioles. Am J Physiol (1984) 0.94
Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim Biophys Acta (1999) 0.93
Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes. Toxicology (2011) 0.92
Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin. Biochim Biophys Acta (1997) 0.92
Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration. Toxicol Appl Pharmacol (1994) 0.91
Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy. Toxicol Appl Pharmacol (2002) 0.89
Age-associated alterations in myocardial contractile properties. Am J Physiol (1972) 0.88
The effect of peroxisome proliferators on mitochondrial bioenergetics. Toxicol Sci (1999) 0.88
Benzoquinone inhibits the voltage-dependent induction of the mitochondrial permeability transition caused by redox-cycling naphthoquinones. Toxicol Appl Pharmacol (1997) 0.88
Development of angiotensin-converting enzyme in fetal rat lungs. Am J Physiol (1979) 0.87
A conceptual framework for predicting the toxicity of reactive chemicals: modeling soft electrophilicity. SAR QSAR Environ Res (2006) 0.87
Inhibition of rat ventricular automaticity by adenosine. Am J Physiol (1985) 0.87
Transcapillary adenosine transport in isolated guinea pig and rat hearts. Am J Physiol (1990) 0.86
Differential mechanisms of cell killing by redox cycling and arylating quinones. Arch Toxicol (1996) 0.86
Determination of 8-hydroxydeoxyguanosine in biological tissue by liquid chromatography/electrospray ionization-mass spectrometry/mass spectrometry. Rapid Commun Mass Spectrom (1996) 0.86
Tamoxifen inhibits induction of the mitochondrial permeability transition by Ca2+ and inorganic phosphate. Toxicol Appl Pharmacol (1998) 0.86
Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction. Cardiovasc Toxicol (2005) 0.85
Angiotensin-converting enzyme in developing lung and kidney. Am J Physiol (1978) 0.85
Continuous monitoring of mitochondrial membrane potential in hepatocyte cell suspensions. J Pharmacol Toxicol Methods (1996) 0.85
Molecular determinants of the species-selective inhibition of brain acetylcholinesterase. Toxicol Appl Pharmacol (1990) 0.83
Differential mechanisms of induction of the mitochondrial permeability transition by quinones of varying chemical reactivities. Toxicol Appl Pharmacol (1995) 0.83
Species-related differences in the inhibition of brain acetylcholinesterase by paraoxon and malaoxon. Toxicol Appl Pharmacol (1987) 0.83
Postnatal development of the renin-angiotensin system in rats. Am J Physiol (1980) 0.82
Selective activation of the sodium-independent, cyclosporin A-sensitive calcium pore of cardiac mitochondria by doxorubicin. Toxicol Appl Pharmacol (1993) 0.82
Myocardial renin is neither necessary nor sufficient to initiate or maintain ventricular hypertrophy. Am J Physiol Regul Integr Comp Physiol (2000) 0.81
Mechanical properties of the copper-deficient rat heart. J Nutr (1982) 0.81
Doxorubicin-induced thiol-dependent alteration of cardiac mitochondrial permeability transition and respiration. Biochemistry (Mosc) (2006) 0.81
Cardiac muscle mechanics from Doca- and aging spontaneously hypertensive rats. Am J Physiol (1978) 0.80
Intrinsic metabolic clearance of parathion and paraoxon by livers from fish and rodents. Toxicol Appl Pharmacol (1987) 0.79
Nonenzymatic oxygen activation and stimulation of lipid peroxidation by doxorubicin-copper. Toxicol Appl Pharmacol (1986) 0.79
Oxygen-dependent effect of microsomes on the binding of doxorubicin to rat hepatic nuclear DNA. Mol Pharmacol (1987) 0.77
Disposition of biogenic amines and angiotensin I by lungs of spontaneously hypertensive rats. Am J Physiol (1980) 0.77
Calcium reintroduction decreases viability of cardiac myocytes from copper-deficient rats. J Nutr (1999) 0.77
Angiotensin II metabolism by tissues from developing rats. Pediatr Res (1981) 0.77
Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats. Toxicol Appl Pharmacol (2001) 0.77
Induction of the mitochondrial permeability transition in vitro by short-chain carboxylic acids. Biochem Biophys Res Commun (2000) 0.77
The physicochemical basis of QSARs for baseline toxicity. SAR QSAR Environ Res (2009) 0.76
Augmented aftercontractions in papillary muscles from rats with cardiac hypertrophy. Am J Physiol (1979) 0.76
Membrane potentials and contractile events of hypertrophied rat cardia muscle. Proc Soc Exp Biol Med (1981) 0.76
Enhanced induction of the mitochondrial permeability transition following acute menadione administration. Arch Biochem Biophys (1995) 0.76
Perfluorooctanoic acid stimulated mitochondrial biogenesis and gene transcription in rats. Toxicology (2009) 0.76
Stimulation of myoglobin-dependent lipid peroxidation by adriamycin. Biochem Biophys Res Commun (1994) 0.76
Adenosine receptor antagonism attenuates angiotensin II effects on adrenergic neurotransmission in the rabbit isolated vas deferens. J Pharmacol Exp Ther (1990) 0.76
Acrylic acid induces the glutathione-independent mitochondrial permeability transition in vitro. Toxicol Sci (1998) 0.76
Urea cycle gene expression is suppressed by PFOA treatment in rats. Toxicol Lett (2010) 0.76
Mechanical properties of cardiac muscle from spontaneously hypertensive rats: accentuated aftercontractions. Proc Soc Exp Biol Med (1977) 0.76
Pseudomonas aeruginosa exotoxin A enhances automaticity and potentiates hypoxic depression of isolated rat hearts. Proc Soc Exp Biol Med (1993) 0.75
Adriamycin-induced oxidation of myoglobin. Biochem Biophys Res Commun (1994) 0.75
Cardiac hypertrophy in copper-deficient rats is not attenuated by angiotensin II receptor antagonist L-158,809. Proc Soc Exp Biol Med (1996) 0.75
Effect of paraquat treatment of rats on disposition of 5-hydroxytryptamine and angiotensin I by perfused lung. Biochem Pharmacol (1979) 0.75
Species differences in the kinetics of the renin-substrate reaction in plasma. J Pharmacol Methods (1980) 0.75
Cardiac norepinephrine and intrinsic properties of isolated hypertrophied hearts from DOCA hypertensive rats. J Mol Cell Cardiol (1984) 0.75
Cancer pain and chronic illness. J Med Assoc Ga (1982) 0.75
Isovolumetric properties of ventricles of spontaneously hypertensive rats. Am J Physiol (1981) 0.75
Aglycosylation and disposition of doxorubicin in isolated rat liver nuclei and microsomes. Drug Metab Dispos (1986) 0.75
Production of high-titer stocks of the English strain of rat cytomegalovirus. J Virol Methods (2000) 0.75
Nonrespiratory metabolic function and morphology of lung following exposure to polybrominated biphenyls in rats. J Toxicol Environ Health (1982) 0.75
Hepatic redox homeostasis following acute adriamycin intoxication in rats. Biochem Pharmacol (1983) 0.75
Cardiac anaphylaxis in isolated guinea pig hearts perfused at constant flow or constant pressure. Proc Soc Exp Biol Med (1987) 0.75
A baseline inhalation toxicity model for narcosis in mammals. SAR QSAR Environ Res (2009) 0.75
The role of redox cycling versus arylation in quinone-induced mitochondrial dysfunction: a mechanistic approach in classifying reactive toxicants. SAR QSAR Environ Res (1995) 0.75
Channel-specific induction of the cyclosporine A-sensitive mitochondrial permeability transition by menadione. J Toxicol Environ Health (1995) 0.75
Disposition of 5-hydroxytryptamine in lungs of developing rats. Am J Physiol (1980) 0.75
Age-related differences in the stoichiometry of the renin-angiotensinogen reaction in rat plasma. Dev Pharmacol Ther (1982) 0.75
Age-related differences in angiotensin I metabolism by isolated perfused rat lungs. Am J Physiol (1980) 0.75